These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13850662)

  • 21. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 22. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW; Goldin A
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract]   [Full Text] [Related]  

  • 23. CHEMOTHERAPY OF ADVANCED MOUSE LEUKEMIA L1210: COMPARISON OF METHOTREXATE ALONE AND IN SEQUENTIAL THERAPY.
    VENDITTI JM; GOLDIN A
    Cancer Res; 1964 Sep; 24():1457-60. PubMed ID: 14221802
    [No Abstract]   [Full Text] [Related]  

  • 24. A new bis-guanylhydrazone with antileukemic properties.
    Marxer A
    Experientia; 1967 Mar; 23(3):173-4. PubMed ID: 6055884
    [No Abstract]   [Full Text] [Related]  

  • 25. OSSAMYCIN, A NEW CYTOTOXIC AGENT.
    SCHMITZ H; JUBINSKI SD; HOOPER IR; CROOK KE; PRICE KE; LEIN J
    J Antibiot (Tokyo); 1965 Mar; 18():82-8. PubMed ID: 14326088
    [No Abstract]   [Full Text] [Related]  

  • 26. SYNTHESIS AND ANTITUMOR ACTIVITY OF 2-AMINO-1-METHYLPURINE- 6-THIONE.
    NOELL CW; SMITH DW; ROBINS RK
    J Med Pharm Chem; 1962 Sep; 5():996-9. PubMed ID: 14056442
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents.
    Hirshaut Y; Weiss GH; Perry S
    Cancer Res; 1969 Sep; 29(9):1732-40. PubMed ID: 5258874
    [No Abstract]   [Full Text] [Related]  

  • 28. Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia.
    LANE M
    J Natl Cancer Inst; 1959 Dec; 23():1347-59. PubMed ID: 14413840
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract]   [Full Text] [Related]  

  • 30. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
    SKIPPER HE; SCHABEL FM; WILCOX WS
    Cancer Chemother Rep; 1964 Feb; 35():1-111. PubMed ID: 14117037
    [No Abstract]   [Full Text] [Related]  

  • 31. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative description of morphologic changes effected by antileukemic agents in L1210 leukemia cells.
    Iwasaki H; Liu YP; Nojyo Y; Ueda T; Nakamura T
    Anticancer Res; 1995; 15(1):133-9. PubMed ID: 7733623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. POTENTIAL ANTICANCER AGENTS. LXII. THE RELATIONSHIP OF CHEMICAL STRUCTURE TO ANTILEUKEMIC ACTIVITY WITH ANALOGS OF 1-METHYL-3-NITRO-1-NITROSOGUANIDINE (NSC-9369). II.
    HYDE KA; ACTON E; SKINNER WA; GOODMAN L; GREENBERG J; BAKER BR
    J Med Pharm Chem; 1962 Jan; 5():1-14. PubMed ID: 14046609
    [No Abstract]   [Full Text] [Related]  

  • 34. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 35. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 36. THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    EVANS JS; MUSSER EA; BOSTWICK L; MENGEL GD
    Cancer Res; 1964 Aug; 24():1285-93. PubMed ID: 14216163
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with Cytoxan.
    THOMAS LB; CHIRIGOS MA; HUMPHREYS SR; GOLDIN A
    J Natl Cancer Inst; 1962 Jun; 28():1355-89. PubMed ID: 13920822
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness of antileukemic agents in mice inoculated with a leukemia L1210 variant resistant to 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196).
    Tyrer DD; Kline I; Gang M; Goldin A; Venditti JM
    Cancer Chemother Rep; 1969 Sep; 53(4):229-41. PubMed ID: 5384463
    [No Abstract]   [Full Text] [Related]  

  • 39. AN EXPERIMENTAL THERAPEUTIC APPROACH TO L1210 LEUKEMIA IN MICE: COMBINED CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM IRRADIATION.
    JOHNSON RE
    J Natl Cancer Inst; 1964 Jun; 32():1333-41. PubMed ID: 14191403
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
    Wilson VL; Jones PA; Momparler RL
    Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.